Clinical Trial

C-TST for Diagnosis of Latent Mycobacterium Tuberculosis Infection in Indonesia

Study acronym: C-TST
Completed
View on ClinicalTrials.gov →
Summary
This is an operational research in household/close contacts of confirmed TB patients to evaluate the effectiveness of C-TST compared to IGRA test in identifying latent TB cases using parameters of effectiveness and safety.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-05-08; most recent amendment 2026-05-31.
Trial Details
NCT Number NCT07587164
Lead Sponsor Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Collaborators: Respiratory Programmatic Implementation and Research Institute (RPRI)
Conditions Latent Tuberculosis Infection (LTBI)
Enrollment 300 participants
Start Date 2025-05-26
Primary Completion 2025-08-21 (estimated)
Study Completion 2025-08-21 (estimated)
Updated on ClinicalTrials.gov 2026-06-03